What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors? By: Benzinga via Benzinga May 21, 2015 at 08:27 AM EDT On Tuesdady, Johnson & Johnson (NYSE: JNJ) and Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) announced this week that they are ... Read More >> Related Stocks: AbbVie Achison Inc Gilead Sciences Johnson & Johnson